Clinical research is at the heart of all medical advances and contributes greatly to improving the quality of medicine that is available to you and your loved ones. Participants in research studies — people just like you — are a critical link in making these discoveries possible.
Austin Regional Clinic (ARC) is currently enrolling patients in the below studies; however, these studies will be closing soon. Both ARC patients and non-ARC patients who fit trial eligibility requirements are welcome to apply. Enroll today to participate!
ARC Clinical Research enrolling studies
- Sanofi PSK05 Clinical Study: A phase III, randomized, modified double-blind, active-controlled, parallel-group, two-arm study to investigate the safety of a four-dose regimen of a 21-valent pneumococcal conjugate vaccine in healthy infants and toddlers.
- Chronic Spontaneous Urticaria (CSU) Clinical Study: This study evaluates the efficacy and safety of EV0756 in people with moderate to severe CSU. CSU is a condition where people have hives and local skin swelling that can show up anywhere on the body and last for six weeks or longer.
All enrolling studies
Learn more by calling ARC Clinical Research at 737-247-7240 or visit ARCclinicalresearch.com.